BDB564811

Aiolos Mouse anti-Human, PE, Clone: S50-895, BD

Manufacturer: BD Biosciences

Select a Size

Pack Size SKU Availability Price
Each of 1 BDB564811-Each-of-1 In Stock ₹ 24,742.00

BDB564811 - Each of 1

₹ 24,742.00

In Stock

Quantity

1

Base Price: ₹ 24,742.00

GST (18%): ₹ 4,453.56

Total Price: ₹ 29,195.56

Antigen

Aiolos

Classification

Monoclonal

Conjugate

PE

Formulation

Aqueous buffered solution containing BSA and ≤0.09% sodium azide.

Immunogen

Human Aiolos Recombinant Protein

Quantity

50 Tests

Primary or Secondary

Primary

Content And Storage

Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.

Applications

Flow Cytometry

Clone

S50-895

Description

AIOLOS; AIO; IKZF3; ZNFN1A3

Host Species

Mouse

Purification Method

Affinity Purified

Regulatory Status

RUO

Target Species

Human

Isotype

IgG1 κ

Related Products

Img

BD Biosciences

BDB562195

--

Img

BD Biosciences

BDB563428

--

Img

BD Biosciences

BDB562259

--

Img

BD Biosciences

BDB563593

--

Img

BD Biosciences

BDB564866

--

Img

BD Biosciences

BDB564814

--

Img

BD Biosciences

BDB562125

--

Img

BD Biosciences

BDB562124

--

Description

  • The S50-895 monoclonal antibody specifically recognizes the transcription factor, Aiolos, which is encoded by IKZF3 , IKAROS family zinc finger 3
  • Aiolos belongs to the Ikaros family of zinc-finger proteins that includes Ikaros and Helios
  • Aiolos can form homodimers or heterodimers with other Ikaros family members
  • Multiple Aiolos isoforms have been described
  • Aiolos is expressed in committed lymphoid progenitors and mature types of T and B lymphocytes, but is not expressed by hematopoietic stem cells
  • Aiolos plays an important role in the control of B lymphocyte differentiation and proliferation and is specifically required for the generation of long-lived, high affinity plasma cells in the bone marrow
  • Aiolos is involved in regulating BCL2 expression and controlling apoptosis in T-cells in an IL2-dependent manner
  • Aberrant expression of IKZF3 has been implicated with leukemogenesis and certain autoimmune diseases.